Browse by Poster Presenter

Skip to main content

ACoP 2024 Main banner

Conference Program

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

R
Rachid, Ousama

College of Pharmacy, QU Health, Qatar University, Doha, Qatar
(W-009) A Physiological-Based Pharmacokinetic (PBPK) Model embedded with Pulmonary Compartmental Absorption and Transit (PCAT™️) Module to Predict Intranasal Ketamine Pharmacokinetics in Pediatric Population
Ousama Rachid
Favorite
Ramakrishnan, Vidya

Genentech, Inc.
(M-095) Population Pharmacokinetic Modeling Informed the Dose of GDC-8264 for a Phase 1b Study in Participants with Acute Graft-Versus-Host Disease
Vidya Ramakrishnan
Favorite
Rao, Rohit

Pfizer
(T-101) A QSP model of atopic dermatitis to accelerate the clinical translation of novel combination therapies
Rohit Rao
Favorite
Rao, Satyajit

Novartis
(T-100) Beyond Subcutaneous Dosing: Efficiency of liver-targeting siRNAs dosed via alternates routes and formulations.
Satyajit Rao
Favorite
Rashid, Jahidur

Vertex Pharmaceuticals, Inc.
(T-019) Simulate modified Nonmem models using NMsim
Jahidur Rashid
Favorite
Ratushny, Alexander

Bristol Myers Squibb
(W-059) Facilitating RP2D decisions for CAR T cell therapy clinical studies using a QSP model
Alexander Ratushny
Favorite
Ravula, Abhigyan

EMD Serono
(W-100) Pharmacometrics-Based Evaluation of Fixed versus Weight-Based Dosing Strategies for Approved Antibody Drug Conjugates (ADC)
Abhigyan Ravula
Favorite
Ray, Ashley

University of Georgia
(T-102) Redefining Multidrug Resistance Quantitatively using Live Cell Functional Data
Ashley Ray
Favorite
Rebello, Juliet

Symbiosis International University, Pune
(W-101) Development of a Population PK model for an inhaled drug
Juliet Rebello
Favorite
Reed, Michael
(W-102) Mathematical optimization of a thrombopoiesis quantitative systems pharmacology (QSP) model
Michael Reed
Favorite
Reilly, Brian

Vertex Pharmaceuticals
(T-103) A model-based simulation workflow enables automated and accurate generation of clinical pharmacology summary statistics, a workflow and case-study.
Brian Reilly
Favorite
Renardy, Marissa

Certara
(M-025) A quantitative systems pharmacology (QSP) model to enable prediction of ARIA-E incidence with anti-Aβ monoclonal antibody therapies for Alzheimer’s disease
Marissa Renardy
Favorite
Reynaldo Fernandez, Gledys

College of Pharmacy, University of Florida
(W-103) Prediction of the Biological Effect of PEG-rHuEPO Candidates in Chronic Kidney Disease Patients using a Middle-out Translation Approach
Gledys Reynaldo Fernandez
Favorite
Richfield, Owen

Yale University
(W-104) Modeling Endothelial Cell-Targeted Polymeric Nanoparticle Delivery in Renal Glomeruli
Owen Richfield
Favorite
Rieger, Theodore

Pfizer
(T-104) Adaptation of the Glucose, Glucagon, Gastric-Inhibitory Peptide, Glucagon-like Peptide-1, and Insulin (4GI) Model for Simulation of Acute Meal Challenges with Infused Antagonists
Theodore Rieger
Favorite
Ruiz-Martinez, Alvaro

Rosa & Co. LLC
(W-102) Mathematical optimization of a thrombopoiesis quantitative systems pharmacology (QSP) model
Alvaro Ruiz-Martinez
Favorite
Ryman, Josiah

EMD Serono
(W-105) Informing Early Trial Design in Oncology Through Clinical Trial Simulations from Population Pharmacokinetic-Tumor Growth Inhibition Models
Josiah Ryman
Favorite
Ryu, Hyunwook

Seoul National University College of Medicine and Hospital
(M-096) Population pharmacokinetics analysis of DA-8010, a novel anti-muscarinic agent
Hyunwook Ryu
Favorite